UK could miss out on hundreds of millions of pounds in off-patent drug savings
Bloomberg reports that an industry group warned of lost savings, with pricing concerns and a lack of usage in the NHS putting drugmakers off.
TLDR
Bloomberg reports that an industry group warned the UK will miss out on savings worth hundreds of millions of pounds on off-patent medicines. Drugmakers are put off by concerns about pricing and a lack of usage in the National Health Service.
Combined views
26.5K
1 Source, first seen 7h ago
4 likes
